Tetrahydrotriazine compounds for treating diseases associated with AMPK activity

摘要

The invention relates to compounds of formula (I) wherein the radicals R1 to R6 have the meaning according to claim 1, and/or physiologically acceptable salts thereof, for the prophylactic or therapeutic treatment and/or monitoring of physiological and/or pathological conditions that are associated with the activity of AMP-activated protein kinase (AMPK). Another object of the invention concerns the use of said compounds for enhancing glucose homeostasis, improving podocytopathy and/or decreasing the production of reactive oxygen species (ROS). The invention also relates to a method for in-vitro diagnosing diabetic nephropathy and a method for screening compounds that reduce podocytopathy, in each case by applying synaptopodin as biomarker.;

主权项

1. A method for treating a mammal for prostate cancer, said method comprising administering a therapeutically effective amount of a compound of formula (I) and/or a physiologically acceptable salt thereof to a mammal in need of such treating wherein the compound of formula (I) is 5,6-dihydro-4-dimethylamino-2-imino-6-methyl-1,3,5-triazine and/or the physiologically acceptable hydrochloride salt thereof.